Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GOSS Gossamer Bio Inc.

交易中 03-04 14:12:24 EST

0.5563

+0.0863

+18.36%

最高0.5620	最低0.4649	成交量1,727万
今开0.4734	昨收0.4700	日振幅20.66%
总市值1.29亿	流通市值1.02亿	总股本2.31亿
成交额911.96万	换手率9.40%	流通股本1.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GOSS","market":"US","secType":"STK","nameCN":"Gossamer Bio Inc.","latestPrice":0.5563,"timestamp":1772651541346,"preClose":0.47,"halted":0,"volume":17274038,"delay":0,"changeRate":0.18361702127659585,"floatShares":183824329,"shares":231456247,"eps":-0.687408,"marketStatus":"交易中","change":0.0863,"latestTime":"03-04 14:12:24 EST","open":0.4734,"high":0.562,"low":0.4649,"amount":9119558.8871072,"amplitude":0.206596,"askPrice":0.5567,"askSize":1600,"bidPrice":0.5539,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.687408,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772658000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1549602000000,"exchange":"NASDAQ","adjPreClose":0.47,"preHourTrading":{"tag":"盘前","latestPrice":0.474,"preClose":0.47,"latestTime":"09:29 EST","volume":422932,"amount":198363.71043687998,"timestamp":1772634578266,"change":0.004,"changeRate":0.008511,"amplitude":0.042979},"postHourTrading":{"tag":"盘后","latestPrice":0.4616,"preClose":0.47,"latestTime":"19:56 EST","volume":253321,"amount":120088.368195,"timestamp":1772585781031,"change":-0.0084,"changeRate":-0.017872,"amplitude":0.053191},"volumeRatio":0.697685,"impliedVol":1.4485,"impliedVolPercentile":0.7291},"requestUrl":"/m/hq/s/GOSS","defaultTab":"news","newsList":[{"id":"2614417820","title":"Gossamer Bio, Inc.盘中异动 早盘大幅下挫5.39%报0.393美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614417820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614417820?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:35","pubTimestamp":1772030109,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时35分，Gossamer Bio, Inc.股票出现异动，股价大幅下挫5.39%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Surrozen Inc C/Wts 01/08/2031 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Quince Therapeutics, Inc.、Ensysce Biosciences, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为157.96%、20.93%、14.22%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Larimar Therapeutics, Inc.、Onkure Therapeutics, Inc.，振幅分别为21.81%、15.45%、11.37%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022522351097a706ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022522351097a706ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"1133744072","title":"Leerink Partners下调Gossamer Bio评级至“与大盘持平”，目标价大幅削减至1美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133744072","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133744072?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:06","pubTimestamp":1771934761,"startTime":"0","endTime":"0","summary":"投资机构Leerink Partners宣布，将生物制药公司Gossamer Bio Inc.的股票评级从“跑赢大盘”下调至“与大盘持平”。与此同时，该机构将其目标股价从6美元大幅调降至1美元，显示出对该公司近期前景的谨慎态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"1116218972","title":"Gossamer Bio股价盘前暴跌80%，其肺部疾病药物未能达到后期试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1116218972","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116218972?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:40","pubTimestamp":1771854013,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 股价在盘前交易中遭遇断崖式下跌，跌幅高达80%，此前该公司宣布其针对肺部疾病研发的药物在关键后期试验中未能达到主要目标。\n这一重大挫折直接源于其核心候选药物的临床试验结果未达预期，导致市场对该公司的前景迅速转向悲观。投资者信心遭受重创，反映出生物科技领域高风险高回报的特性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"1131316037","title":"Gossamer Bio公布Seralutinib治疗肺动脉高压的III期Prosera研究顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1131316037","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131316037?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:05","pubTimestamp":1771851937,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. (股票代码：GOSS) 近日披露了其III期临床试验Prosera研究的顶线数据。该研究旨在评估候选药物Seralutinib在肺动脉高压患者中的疗效与安全性。\n这项关键性研究的结果标志着公司在肺动脉高压治疗领域的重要进展。顶线数据的公布为后续研发决策提供了关键依据，也将影响该药物的上市申请策略。\n肺动脉高压作为一种罕见且严重的疾病，目前仍存在未满足的临床需求。Seralutinib若最终获批，有望为患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"1106797748","title":"Gossamer Bio遗憾未能达到主要终点预设严格统计阈值 结果仍优于传统0.05显著性水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1106797748","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106797748?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:03","pubTimestamp":1771851797,"startTime":"0","endTime":"0","summary":"生物制药公司Gossamer Bio最新临床试验数据显示，其研究项目的主要终点指标虽以微小差距未达到预设的严格统计阈值，但实验结果依然突破了传统统计学中0.05的显著性水平门槛。这一结果既反映出研究设计的前瞻性，也凸显出药物开发过程中统计功效与临床意义之间的复杂平衡。\n尽管未能完全满足预设的严苛标准令研发团队感到遗憾，但跨越传统P值界限的成果仍为后续研究提供了重要数据支撑。该统计结果暗示治疗趋势的存在，为探索更精准的患者亚群分析及优化临床试验方案创造了空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GOSS","BK4505"],"gpt_icon":0},{"id":"2601360600","title":"Gossamer Bio, Inc.盘中异动 下午盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601360600?lang=zh_cn&edition=full","pubTime":"2026-01-08 02:21","pubTimestamp":1767810082,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日02时21分，Gossamer Bio, Inc.股票出现波动，股价快速下跌5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.18%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Monte Rosa Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Aspire Biopharma Holdings, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为1082.60%、332.28%、286.69%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Novabay Pharmaceuticals, Inc.、Aspire Biopharma Holdings, Inc.，振幅分别为50.85%、50.20%、41.43%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010802212297a13560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010802212297a13560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","BK4505"],"gpt_icon":0},{"id":"2600609754","title":"Gossamer Bio, Inc.盘中异动 早盘股价大跌5.03%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600609754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600609754?lang=zh_cn&edition=full","pubTime":"2026-01-02 23:08","pubTimestamp":1767366510,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日23时08分，Gossamer Bio, Inc.股票出现波动，股价急速下跌5.03%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Jasper Therapeutics Inc C/Wts 24/09/2026 、Pepgen Inc.、Geovax Labs, Inc.涨幅较大，Can Fite Biopharma Ltd、Outlook Therapeutics, Inc.、Sensei Biotherapeutics, Inc.较为活跃，换手率分别为82.97%、54.56%、52.39%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为45.14%、34.51%、21.34%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102230830a6ebfbba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102230830a6ebfbba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2593428874","title":"Gossamer Bio, Inc.盘中异动 急速跳水5.04%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593428874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593428874?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:03","pubTimestamp":1766502188,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日23时03分，Gossamer Bio, Inc.股票出现波动，股价快速下挫5.04%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Lexaria Bioscience Corp.、Pmgc Holdings Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为63.57%、25.39%、23.66%，振幅较大的相关个股有Geovax Labs, Inc.、健永生技、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为34.42%、32.32%、27.78%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230309a6c6775a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230309a6c6775a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2592917616","title":"Gossamer Bio, Inc.盘中异动 早盘股价大涨5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592917616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592917616?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:32","pubTimestamp":1765981951,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时32分，Gossamer Bio, Inc.股票出现异动，股价快速拉升5.90%。截至发稿，该股报3.77美元/股，成交量13.972万股，换手率0.06%，振幅3.37%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Vyne Therapeutics Inc.、Aditxt, Inc.涨幅较大，Pmgc Holdings Inc.、Aditxt, Inc.、Vyne Therapeutics Inc.较为活跃，换手率分别为1010.00%、913.38%、244.12%，振幅较大的相关个股有Aditxt, Inc.、Vyne Therapeutics Inc.、Mindwalk Holdings Corp.，振幅分别为14.79%、13.36%、11.31%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722323197a06e75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722323197a06e75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","BK4505"],"gpt_icon":0},{"id":"2588909825","title":"Gossamer Bio, Inc.盘中异动 急速下挫5.10%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588909825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588909825?lang=zh_cn&edition=full","pubTime":"2025-12-03 04:40","pubTimestamp":1764708012,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日04时40分，Gossamer Bio, Inc.股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.98美元/股，成交量283.654万股，换手率1.23%，振幅4.94%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Polyrizon Ltd.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Moolec Science Sa涨幅较大，Polyrizon Ltd.、Clearmind Medicine Inc.、Jasper Therapeutics, Inc.较为活跃，换手率分别为13714.42%、348.46%、202.94%，振幅较大的相关个股有Polyrizon Ltd.、Akari Therapeutics Plc、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为79.43%、70.43%、63.55%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120304401295275148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120304401295275148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"1162764197","title":"Gossamer Bio宣布根据纳斯达克上市规则5635(C)(4)提供诱导授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1162764197","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162764197?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:12","pubTimestamp":1763572330,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. ::*GOSSAMER BIO宣布根据纳斯达克上市规则5635(C)(4)提供诱导授予","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GOSS","BK4505"],"gpt_icon":0},{"id":"2574345580","title":"Gossamer Bio, Inc.盘中异动 早盘快速跳水5.08%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574345580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574345580?lang=zh_cn&edition=full","pubTime":"2025-10-10 21:51","pubTimestamp":1760104303,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日21时51分，Gossamer Bio, Inc.股票出现异动，股价快速下跌5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Gyre Therapeutics, Inc.、Atyr Pharma, Inc.涨幅较大，Aditxt, Inc.、Cdt Equity Inc.、Intensity Therapeutics, Inc.较为活跃，换手率分别为292.50%、50.70%、38.15%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Cabaletta Bio, Inc.、Intensity Therapeutics, Inc.，振幅分别为39.27%、18.59%、16.83%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102151439726a8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102151439726a8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2572650461","title":"Gossamer Bio, Inc.盘中异动 大幅上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572650461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572650461?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:33","pubTimestamp":1759498394,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时33分，Gossamer Bio, Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报2.61美元/股，成交量9.1675万股，换手率0.04%，振幅4.03%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Ovid Therapeutics Inc.、Reviva Pharmaceuticals Holdings, Inc.涨幅较大，Ovid Therapeutics Inc.、Palisade Bio, Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为42.99%、29.15%、13.65%，振幅较大的相关个股有Palisade Bio, Inc.、Neurogene Inc.、Yd Bio Limited，振幅分别为14.71%、11.82%、10.12%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213314a6ac2d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213314a6ac2d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"2572587727","title":"Gossamer Bio, Inc.盘中异动 快速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572587727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572587727?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:05","pubTimestamp":1759241131,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日22时05分，Gossamer Bio, Inc.股票出现波动，股价大幅下跌5.32%。截至发稿，该股报2.67美元/股，成交量27.0992万股，换手率0.12%，振幅6.02%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Scisparc Ltd.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Anaptysbio, Inc.涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1742.43%、285.41%、256.74%，振幅较大的相关个股有Scisparc Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Anaptysbio, Inc.，振幅分别为28.48%、26.06%、24.54%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220531a6a894f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220531a6a894f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"1154713854","title":"Respira Therapeutics与Gossamer Bio Inc.达成协议，Gossamer Bio获得从Samsara Biocapital收购Respira的选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1154713854","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154713854?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:41","pubTimestamp":1758800508,"startTime":"0","endTime":"0","summary":"Respira Therapeutics与Gossamer Bio Inc.达成协议，授予Gossamer Bio从Samsara Biocapital收购Respira的选择权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"1195142945","title":"Gossamer Bio Inc - 若期权获得行使，公司预计RT234临床试验最早将于2027年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1195142945","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195142945?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:35","pubTimestamp":1758800120,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc表示，如果期权得到行使，公司预计不会在2027年之前启动RT234的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"1140821658","title":"Gossamer Bio：Respira股东有资格获得部分里程碑付款及Rt234潜在净销售额的高个位数特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1140821658","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140821658?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:34","pubTimestamp":1758800089,"startTime":"0","endTime":"0","summary":"Gossamer Bio宣布，Respira的股东有资格获得部分里程碑付款，以及Rt234潜在净销售额的高个位数特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"1199232920","title":"Gossamer Bio Inc.签署期权协议，拟收购Respira Therapeutics及其核心候选药物Rt234——一款用于肺动脉高压的按需吸入式伐地那非","url":"https://stock-news.laohu8.com/highlight/detail?id=1199232920","media":"美股速递","labels":["corporation","productRelease","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199232920?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:31","pubTimestamp":1758799900,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.已与Respira Therapeutics达成期权协议，计划收购该公司及其主要候选药物Rt234。Rt234是一款创新的按需吸入式伐地那非药物，专门用于治疗肺动脉高压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2568832992","title":"Gossamer Bio, Inc.盘中异动 早盘快速拉升5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568832992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568832992?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:48","pubTimestamp":1758203285,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时48分，Gossamer Bio, Inc.股票出现波动，股价大幅拉升5.02%。截至发稿，该股报3.14美元/股，成交量39.644万股，换手率0.17%，振幅3.85%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，89Bio, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.涨幅较大，Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃，换手率分别为2072.35%、917.35%、270.64%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Replimune Group, Inc.，振幅分别为52.69%、31.72%、22.59%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214805a4cddcfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214805a4cddcfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"2518027458","title":"Gossamer Bio, Inc.盘中异动 早盘急速下跌5.37%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518027458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518027458?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:24","pubTimestamp":1741620245,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时24分，Gossamer Bio, Inc.股票出现波动，股价快速下跌5.37%。截至发稿，该股报1.15美元/股，成交量34.5502万股，换手率0.15%，振幅6.20%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3606.98%、1130.61%、802.76%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为51.05%、49.87%、41.36%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023240596404fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023240596404fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gossamerbio.com","stockEarnings":[{"period":"1week","weight":0.1314},{"period":"1month","weight":-0.7939},{"period":"3month","weight":-0.8626},{"period":"6month","weight":-0.8127},{"period":"1year","weight":-0.6017},{"period":"ytd","weight":-0.8484}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0052},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1654},{"period":"ytd","weight":-0.0023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gossamer Bio, Inc.于2015年10月26日根据特拉华州法律以FSG, Bio, Inc.的名字注册成立，并于2017年更名为Gossamer Bio, Inc.,Gossamer Bio, Inc.该公司是一家临床阶段的生物制药公司，专注于赛拉鲁替尼治疗肺动脉高压或PAH的开发和商业化。该公司的目标是成为行业领导者，并提高患有肺动脉高压或PH的患者的生活。为实现这一目标，该公司集结了一群经验丰富、技术精湛的行业资深人士、科学家、临床医生和来自领先生物技术和制药公司的关键意见领袖，以及来自世界各地的领先学术中心。该公司打算保持科学严谨和包容的企业文化，员工努力为患者带来更好的治疗选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.040994},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.054406},{"month":3,"riseRate":0.125,"avgChangeRate":-0.090419},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.093097},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.004094},{"month":6,"riseRate":0.714286,"avgChangeRate":0.13683},{"month":7,"riseRate":0.571429,"avgChangeRate":0.129679},{"month":8,"riseRate":0.714286,"avgChangeRate":0.097398},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.027644},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.109871},{"month":11,"riseRate":0.571429,"avgChangeRate":0.095879},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.08654}],"exchange":"NASDAQ","name":"Gossamer Bio Inc.","nameEN":"Gossamer Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gossamer Bio Inc.,GOSS,Gossamer Bio Inc.股票,Gossamer Bio Inc.股票老虎,Gossamer Bio Inc.股票老虎国际,Gossamer Bio Inc.行情,Gossamer Bio Inc.股票行情,Gossamer Bio Inc.股价,Gossamer Bio Inc.股市,Gossamer Bio Inc.股票价格,Gossamer Bio Inc.股票交易,Gossamer Bio Inc.股票购买,Gossamer Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}